Invesco’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Invesco’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-21,461	Closed	-$997K	–	3950
2023 Q2	$997K	Buy	21,461 +2,421	+13%	+$83.7K	﹤0.01%	2898
2023 Q1	$545K	Sell	19,040 -455	-2%	-$13.5K	﹤0.01%	3214
2022 Q4	$608K	Buy	+19,495	New	+$636K	﹤0.01%	3187

Invesco's DICE Position: Q3 2023 in Review

Invesco sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 21,461 shares — an estimated $997K sold.

Invesco first reported a position in DICE in Q4 2022 and held it in 3 quarters. The position peaked at $997K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Invesco reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Invesco sold 21,461 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $997K.
Invesco first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
Invesco's DICE Therapeutics, Inc. Common Stock position peaked at $997K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Invesco's 13F filing for Q3 2023, filed 13 Nov 2023.